| http://www.w3.org/ns/prov#value | - Agent: Calcimedica, Inc.20110257176 - Nitrogen heterocycle derivatives as proteasome modulators: s20110257178 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes: The present invention provides novel pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the sa
|
